Prevalence of Drug–Drug Interactions in Primary Care Prescriptions in Egypt: A Cross-Sectional Retrospective Study K Abdelkawy, M Kharouba, K Shendy, O Abdelmagged, N Galal, M Tarek, ... Pharmacy 11 (3), 106, 2023 | 3 | 2023 |
Potential Cardiovascular drug interactions in Egypt: incidence, outcomes, mechanism, and management K Sobhy, O AbdelMagged, K Abdelaty, D Khalil, M Abdelgaied Kafrelsheikh Veterinary Medical Journal 19 (2), 22-27, 2021 | 3 | 2021 |
The impact of metformin use on the outcomes of relapse-remitting multiple sclerosis patients receiving interferon beta 1a: an exploratory prospective phase II open-label … MY Abdelgaied, MH Rashad, HM El-Tayebi, MH Solayman Journal of Neurology 271 (3), 1124-1132, 2024 | 1 | 2024 |
Ozonated Oil for the Treatment of Skin Disorders: A Truth or Myth? : A Systematic Review S Araby, M Abdelgaied, M Solayman Biomed J Sci & Tech Res | BJSTR. 51 (2), 42619-42627, 2023 | 1 | 2023 |
Unveiling the lockdown effects: exploring behavior, dietary habits and weight changes in rural Egypt during COVID-19 lockdown: a cross-sectional retrospective study MR Saleh, MY Abdelgaied, N Galal, M Tarek, A Fouda, K Abdelkawy Journal of Health, Population and Nutrition 43 (1), 85, 2024 | | 2024 |
Correction to: The impact of metformin use on the outcomes of relapse‑remitting multiple sclerosis patients receiving interferon beta 1a: an exploratory prospective phase II … MY Abdelgaied, MH Rashad, HM El-Tayebi, MH Solayman Journal of neurology 271 (5), 2925, 2024 | | 2024 |
Common Neuropsychiatric Drug Interactions in Egypt That Require Clinical Interventions: A Retrospective Study in Delta Region MYA , Khloud Shendy, Omar Abdelmagged, Naira Galal, Mai Tarek, Abdalla Essa ... Archives of Pharmacy & Pharmacology Research 4 (2), 2024 | | 2024 |
What's your cup of tea? The role of herbal compounds in the management of multiple sclerosis MY Abdelgaied, MK Abd El-Aziz, NS Amin, HM El Tayebi Multiple Sclerosis and Related Disorders 76, 104799, 2023 | | 2023 |
Drug Repurposing Using Metformin to Improve the Therapeutic Outcome in Multiple Sclerosis Patients Receiving Interferon Beta 1a M Youssef, B Pharm 2023 ACCP Virtual Poster Symposium (May 23 and 24), 2023 | | 2023 |
Statins Increase the Bioavailability of Fixed-Dose Combination of Sofosbuvir/Ledipasvir by Inhibition of P-glycoprotein KS Abdelkawy, F Belal, AE Abdelaziz, HA Elmekawy, MY Abdelgaied, ... Drug Research 72 (06), 319-326, 2022 | | 2022 |